Fierce Pharma October 4, 2024
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines.
The grant comes from the Department of Health and Human Services’ Center for Biomedical Advanced Research and Development Authority (BARDA) under a national preparedness initiative, the Administration for Strategic Preparedness and Response said Friday.
The three companies will fill and finish additional doses of their influenza A(H5) vaccines, turning bulk materials into ready-to-use vials or syringes that can be immediately distributed if needed.
The manufacturers will also make additional bulk antigens that match the circulating bird flu strains. And Sanofi, in an ongoing partnership with BARDA, will preserve a continuous supply of domestic eggs...
Today's Sponsors
Today's Sponsor